IBD Therapeutic Drug Monitoring Thresholds - Infliximab > 7 mcg/ml - Adalimumab > 8 mcg/ml - Certolizumab > 15 mcg/ml - Golimumab > 1 mcg/ml - Vedolizumab > 14 mcg/ml - Ustekinumab > 4.5 mcg/ml #IBD #TDM #Therapeutic #Drug #Monitoring #Thresholds #management #gastroenterology #pharmacology